A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients

Cyclin dependent kinases 4/6 (CDK4/6) inhibitors gained an essential role in the treatment of metastatic breast cancer. Nevertheless, data regarding their use in combination with radiotherapy are still scarce. We performed a retrospective preliminary analysis of breast cancer patients treated at our...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerini, Andrea Emanuele, Pedretti, Sara, Salah, Emiliano, Simoncini, Edda Lucia, Maddalo, Marta, Pegurri, Ludovica, Pedersini, Rebecca, Vassalli, Lucia, Pasinetti, Nadia, Peretto, Gloria, Triggiani, Luca, Costantino, Gianluca, Figlia, Vanessa, Alongi, Filippo, Magrini, Stefano Maria, Buglione, Michela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423932/
https://www.ncbi.nlm.nih.gov/pubmed/32788596
http://dx.doi.org/10.1038/s41598-020-70430-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423932/
https://www.ncbi.nlm.nih.gov/pubmed/32788596
http://dx.doi.org/10.1038/s41598-020-70430-2

Ejemplares similares